Search research articles
Contact Us
Filters
Showing results (581-590 of 585) with videos related to
Page
of 59
Sort By:
You have reached the last page of results.
This site can display upto 585 results.
Journal of Medicinal Chemistry
|
February 23, 2023
Correction to "Discovery, Characterization, and Structure-Based Optimization of Small-Molecule In Vitro and In Vivo Probes for Human DNA Polymerase Theta"
Martin L Stockley, Giovanni Benedetti, Peter Blencowe, et al.
Journal of Medicinal Chemistry
|
September 17, 2025
Fragment-Based Discovery and Structure-Led Optimization of MSC778, the First Potent, Selective, and Orally Bioavailable FEN1 Inhibitor
Sam E Mann, Julien Lefranc, Omar Alkhatib, et al.
Nature Communications
|
June 18, 2021
Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance
Diana Zatreanu, Helen M R Robinson, Omar Alkhatib, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 28, 2024
Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types
Patrick G Pilié, Virginia Giuliani, Wei-Lien Wang, et al.
American Journal of Human Genetics
|
January 20, 2022
Rare germline heterozygous missense variants in BRCA1-associated protein 1, BAP1, cause a syndromic neurodevelopmental disorder
Sébastien Küry, Frédéric Ebstein, Alice Mollé, et al.
Page
of 59
Search research articles
Search
Showing results (581-590 of 585) with videos related to
Sort By:
Page
of 59
You have reached the last page of results.
This site can display upto 585 results.
Journal of Medicinal Chemistry
|
February 23, 2023
Correction to "Discovery, Characterization, and Structure-Based Optimization of Small-Molecule In Vitro and In Vivo Probes for Human DNA Polymerase Theta"
Martin L Stockley, Giovanni Benedetti, Peter Blencowe, et al.
Journal of Medicinal Chemistry
|
September 17, 2025
Fragment-Based Discovery and Structure-Led Optimization of MSC778, the First Potent, Selective, and Orally Bioavailable FEN1 Inhibitor
Sam E Mann, Julien Lefranc, Omar Alkhatib, et al.
Nature Communications
|
June 18, 2021
Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance
Diana Zatreanu, Helen M R Robinson, Omar Alkhatib, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 28, 2024
Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types
Patrick G Pilié, Virginia Giuliani, Wei-Lien Wang, et al.
American Journal of Human Genetics
|
January 20, 2022
Rare germline heterozygous missense variants in BRCA1-associated protein 1, BAP1, cause a syndromic neurodevelopmental disorder
Sébastien Küry, Frédéric Ebstein, Alice Mollé, et al.
Page
of 59